F:\nanderson\web site\np schedules\npschedulese.vp
New Brunswick Prescription Drug Program Formulary:
Appendix IV - Special Authorization
New Brunswick Prescription Drug Program
Formulary: Appendix IV - Special Authorization Drugs Excluded
Bimatroprost (Lumigan) A-13Botulinum Toxin Type A (Botox) A-13Buserelin Acetate (Suprefact) A-14Capecitabine (Xeloda) A-15Celecoxib (Celebrex) A-16Ciprofloxacine (Cipro and generic brands) A-16Ciprofloxacin/hydrocortisone (Cipro HC Otic solution) A-16Clozapine (Clozaril and generic brands) A-17Cyproterone Acetate (Androcur and generic brands) A-17Delta-9-Tetrahydrocannabinol (Marinol) A-18Etanercept (Enbrel) A-20Fentanyl (Duragesic) A-21Filgrastim (Neupogen-Amgen) A-22Fludarabine (Fludara) A-23Flutamide (Euflex and generic brands) A-23Gabapentin (Neurontin and generic brands) A-24Ganciclovir (Cytovene) A-25Goserelin Acetate (Zoladex) A-26Imatinib (Gleevec) A-26Imiquimod (Aldara) A-27Infliximab (Remicade) A-27Interferon Alfa-2B Ribavirin (Rebetron) A-29Lamivudine (Heptovir) A-29Lamotrigine (Lamictal and generic brands) A-29Latanoprost (Xalatan) A-30Latanoprost/Timolol (Xalacom) A-30Leflunomide (Arava) A-30Leuprolide (Lupron and Lupron Depot) A-30Levetiracetam (Keppra) A-31Linezolid (Zyvoxam) A-31Nafarelin Acetate (Synarel) A-32Naltrexone (Revia) A-32Nilutamide (Anadron) A-33Octreotide Acetate (Sandostatin and Sandostatin Lar) A-34Ondansetron (Zofran) A-35Oxcarbazepine (Trileptal) A-35Oxycodone (Oxy IR and Oxycontin CR) A-35 and A-36Peginterferon Alfa-2A (Pegasys) A-36Peginterferon Alfa-2B+Ribavirin (Pegetron) A-36Quetiapine (Seroquel) A-38Rifabutin (Mycobutin) A-39Riluzole (Rilutek) A-39Rivastigmine (Exelon) A-40Sevelamer (Renagel) A-42
Nurses Association of New BrunswickNurse Practitioner Schedules - Revised October 2005
New Brunswick Prescription Drug Program Formulary:
Appendix IV - Special Athorization
Drugs Excluded con’t
Sirolimus (Rapamune) A-42Somatropine (Humatrope) (Saizen) A-43Tacrolimus (Protopic) A-43Thyrotropin Alpha (Thyrogen) A-44Tizanidine (Zanaflex) A-45Tobramycin (Tobi) A-45Travoprost (Travatan) A-45Tretinoin (Vesanoid) A-46Tryptophan (Tryptan and generic brands) A-46Ursodiol (Urso) (Urso DS) A-46Valganciclovir (Valcyte) A-46Vigabatrin (Sabril) A-47
Drugs Limited/For Maintenance
Anastrozole (Arimidex) A-12Atovaquone (Mepron) A-12Bosentan (Tracleer) A-13Bupropion Hydrochloride (Wellbutrin SR) A-14Calcitonin Salmon (Miacalcin, Apo-Calcitonin) A-15Desmopressin (DDAVP) A-18Dipyridamole Extended Release/ASA Immediate Release (Aggrenox) A-18Donepezil (Aricept) A-18Entacapone (Comtan) A-19Epoetin Alfa (Eprex) A-20Exemestane (Aromasin) A-20Finasteride (Proscar) A-23Galantamine (Reminyl) A-24Insulin Aspart (Novorapid) A-28Insulin Lispro (Humalog) A-28Letrozole (Femara) A -30Raloxifene (Evista) A-38Risperidone (Risperdal) (Risperdal M) A-40Tamsulosin Hydrochloride (Flomax) A-43• Controlled Drugs except as permitted by the
Controlled Drugs and Substances Act
Nurse Practitioner Schedules - Revised October 2005
Source: http://www.nanb.nb.ca/PDF/Publications/General_Publications/ScheduleAnnexeIVE.pdf
Pharmakogenetik - patientenindividuell therapieren Information für Heilberufe Die Pharmakogenetik befasst sich mit dem Einfluss genetischer Variabilität auf die Arzneimittelwirkung. Als innovativer Teil der Pharmakologie gewinnt die noch am Anfang stehende Wissenschaft zunehmende Bedeutung am Arzneimittelmarkt, während bereits heute schon viele Forschungsarbeiten mit brauchbaren Erge
Postcoital treatment with levonorgestrel does not disruptA.L. Müller, C.M. Llados, H.B. Croxatto* Pontificia Universidad Católica a de Chile, Facultad de Ciencias Biológicas, Unidad de Reproducción y Desarrollo, Av. Alameda Bernardo O’Higgins Received 28 October 2002; received in revised form 8 January 2003; accepted 13 January 2003 Levonorgestrel (LNG), a progestin widely u
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |O |
P |Q |
R |S |
T |U |
V |
W |
X |
Y |Z |0-9 |